298 Feasibility study of concurrent cisplatin/etoposide (PE) and thoracic radiotherapy (TRT) followed by weekly dose intensive regimen (CODE) with human granulocyte-colony stimulating factor (G-CSF) for limited stage (LS) small cell lung cancer (SCLC): Report of a Japan clinical oncology group study (JCOG-9509)

✍ Scribed by Kubota, K.; Nishiwaki, Y.; Furuse, K.; Fukuoka, M.; Takada, M.; Ariyoshi, Y.; Kurita, Y.; Saijo, N.

• Book ID: 122635191
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 154 KB
• Volume: 18
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(97)89683-3